GLYCOPYRROLATE Side Effects

6972392-0 | Aspiration, Vomiting
on Aug 27, 2010 Female patient from UNITED KINGDOM , child 2 years of age, was diagnosed with salivary hypersecretion and was treated with Glycopyrrolate (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration, vomiting. Glycopyrrolate dosage: 0.050 Mg/kg, Unk. During the same period patient was treated with HYOSCINE (View Hyoscine Review and Hyoscine Label ).

6690360-3 | Underdose
Patient was taking Glycopyrrolate (View Usage). Patient had the following side effects: underdose on Apr 19, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, . Glycopyrrolate dosage: .

6266655-4 | Abdominal Pain, Chills, Depressed Level Of Consciousness, Dizziness, Dyskinesia, Headache, Influenza Like Illness, Opisthotonus, Post Procedural Complication
Adverse event was reported on Jun 22, 2009 by a Female patient taking Glycopyrrolate (View Usage) (Dosage: 0.2 Mg Intravenous) . Location: UNITED STATES , 26 years of age, After Glycopyrrolate was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), chills, depressed level of consciousness, dizziness (What is dizziness?), dyskinesia, headache (What is headache?), influenza like illness, opisthotonus, post procedural complication. During the same period patient was treated with PROPOFOL (100 Mg Intravenous) (View Propofol Review and Propofol Label ), MIDAZOLAM HCL (1mg Intravenous) (View Midazolam Hcl Review and Midazolam Hcl Label ), LIDOCAINE (40 Mg Intravenous) (View Lidocaine Review and Lidocaine Label ), FENTANYL 100 (50 Mcg Intravenous) (View Fentanyl-100 Review and Fentanyl-100 Label ), PHYSOSTIGMINE (View Physostigmine Review and Physostigmine Label ), ROMAZICON (View Romazicon Review and Romazicon Label ). Patient was hospitalized.

5812652-X | Condition Aggravated
on Jul 14, 2008 Male patient from UNITED STATES , 26 years of age, was treated with Glycopyrrolate (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated. Glycopyrrolate dosage: 2 Mg Twice Daily 047.


5690341-2 | Cardiac Arrest, Procedural Complication
on Mar 31, 2008 Female patient from UNITED STATES , 66 years of age, weighting 150.0 lb, was treated with Glycopyrrolate (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), procedural complication. Glycopyrrolate dosage: . During the same period patient was treated with NEOSTIGMINE METHYLSULFATE INJ 1 MG/ ML, 10 ML BAXTER (View Neostigmine Methylsulfate Inj 1 Mg/ Ml, 10 Ml Baxter Review and Neostigmine Methylsulfate Inj 1 Mg/ Ml, 10 Ml Baxter Label ).

5689918-X | Cardiac Arrest
Patient was taking Glycopyrrolate (View Usage). After Glycopyrrolate was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?) on Mar 31, 2008 from UNITED STATES Additional patient health information: Male patient , 52 years of age, weighting 160.0 lb, . Glycopyrrolate dosage: . During the same period patient was treated with NEOSTIGMINE METHYLSULFATE INJ 1 MG/ML, 10 ML BAXTER (View Neostigmine Methylsulfate Inj 1 Mg/ml, 10 Ml Baxter Review and Neostigmine Methylsulfate Inj 1 Mg/ml, 10 Ml Baxter Label ).

5578846-6 | Discomfort, Lymphocyte Percentage Increased, Oxygen Saturation Decreased, Pyrexia, Restlessness, Sinus Tachycardia, Urinary Tract Infection Enterococcal, Urinary Tract Infection Staphylococcal, White Blood Cell Count Increased
Adverse event was reported on Dec 20, 2007 by a Female patient taking Glycopyrrolate (View Usage) (Dosage: 12.5 Ml Tid, Po) was diagnosed with drooling and. Location: UNITED STATES , 18 years of age, weighting 53.00 lb, Patient experienced the following unwanted or unexpected effects: discomfort, lymphocyte percentage increased, oxygen saturation decreased, pyrexia, restlessness, sinus tachycardia, urinary tract infection enterococcal, urinary tract infection staphylococcal, white blood cell count increased. During the same period patient was treated with DANTROLENE SODIUM (View Dantrolene Sodium Review and Dantrolene Sodium Label ), ZANTAC (View Zantac Review and Zantac Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), REGLAN (View Reglan Review and Reglan Label ), CARNITINE (CARNITINE) (View Carnitine (carnitine) Review and Carnitine (carnitine) Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), MIRALAX (View Miralax Review and Miralax Label ). Patient was hospitalized.